TitlePatient and Other Stakeholder Engagement in Patient-Centered Outcomes Research Institute Funded Studies of Patients with Kidney Diseases.
Publication TypeJournal Article
Year of Publication2016
AuthorsCukor, D, Cohen, LM, Cope, EL, Ghahramani, N, S Hedayati, S, Hynes, DM, Shah, VO, Tentori, F, Unruh, M, Bobelu, J, Cohen, S, Dember, LM, Faber, T, Fischer, MJ, Gallardo, R, Germain, MJ, Ghahate, D, Grote, N, Hartwell, L, Heagerty, P, Kimmel, PL, Kutner, N, Lawson, S, Marr, L, Nelson, RG, Porter, AC, Sandy, P, Struminger, BB, Subramanian, L, Weisbord, S, Young, B, Mehrotra, R
JournalClin J Am Soc Nephrol
Volume11
Issue9
Pagination1703-12
Date Published2016 Sep 07
ISSN1555-905X
KeywordsCommunity-Based Participatory Research, Humans, Kidney Diseases, Patient Outcome Assessment, Patient Participation, Patient Selection, Stakeholder Participation
Abstract
 

Including target populations in the design and implementation of research trials has been one response to the growing health disparities endemic to our health care system, as well as an aid to study generalizability. One type of community-based participatory research is "Patient Centered-Research", in which patient perspectives on the germane research questions and methodologies are incorporated into the study. The Patient-Centered Outcomes Research Institute (PCORI) has mandated that meaningful patient and stakeholder engagement be incorporated into all applications. As of March 2015, PCORI funded seven clinically-focused studies of patients with kidney disease. The goal of this paper is to synthesize the experiences of these studies to gain an understanding of how meaningful patient and stakeholder engagement can occur in clinical research of kidney diseases, and what the key barriers are to its implementation. Our collective experience suggests that successful implementation of a patient- and stakeholder-engaged research paradigm involves: (1) defining the roles and process for the incorporation of input; (2) identifying the particular patients and other stakeholders; (3) engaging patients and other stakeholders so they appreciate the value of their own participation and have personal investment in the research process; and (4) overcoming barriers and challenges that arise and threaten the productivity of the collaboration. It is our hope that the experiences of these studies will further interest and capacity for incorporating patient and stakeholder perspectives in research of kidney diseases.

DOI10.2215/CJN.09780915
Alternate JournalClin J Am Soc Nephrol
PubMed ID27197911
PubMed Central IDPMC5012486